Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China

Clinical trial NCT02668640 · COMPLETED

Trial details

NCT number: NCT02668640
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2016-05-01
Primary completion: 2018-06-12
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.